From VALANX Biotech Apr 15 2026 VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug discovery, today announced the formation of its Scientific Advisory Board (SAB), appointing John Lambert as Chair, with Morris Rosenberg and Peter de Waele serving alongside. The newly formed SAB will provide independent scientific and strategic guidance, bridging the gap between research and clinical application to advance the Company's antibody-